Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Added: 8 months ago Source:  Radcliffe Cardiology
The long-term utility of beta-blockers following an uncomplicated myocardial infarction (MI) remains a subject of clinical debate. New secondary results from the AβYSS trial (Assessment of β-blocker interruption one Year after an uncomplicated myocardial infarction on Safety and Symptomatic cardiac events requiring hospitalization) reveal that interrupting this therapy leads to sustained… View more
Job title: Professor of Medicine and Director of the Division of Cardiology
Author(s): Narendra Singh Added: 4 months ago
AHA 2025 — In this interview, Dr Narendra Singh (NSC Cardiology, Atlanta, US) reviews the latest AHA data on etripamil, an investigational intranasal, nondihydropyridine calcium channel blocker for the rapid self-termination of paroxysmal supraventricular tachycardia (PSVT).Dr Singh discusses the burden of PSVT, key findings from randomized and open-label studies, conversion rates with single and… View more
Prof Carlos Morillo is a cardiac electrophysiologist, currently serving in the Chief Division of Cardiology at theLibin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada. Prof Morillo has extensively researched Chagas disease since 1990, and was involved in the initial studies related to autonomic control in the different stages of the disease and the use of beta… View more
Job title: Professor
Marco Metra is Full Professor of Cardiology and Director of the Institute of Cardiology of the Civil Hospital and University of Brescia, Italy, and Editor-in-Chief of theEuropean Journal of Heart Failureand Senior Consulting Editor of theEuropean Heart Journal. Prof Metra has been principal investigator and member of the Executive or Steering Committees of many trials in patients with heart… View more
Author(s): Rick Veasey Added: 1 year ago
ESC Congress 24 — SHAM-PVI study finds pulmonary vein isolation effective in reducing atrial fibrillation (AF) episodes, improving quality of life.We are joined onsite by Dr Rick Veasey (Eastbourne District General Hospital, Eastbourne, UK) to discuss the findings from a SHAM-PVI, a randomized sham-controlled study of pulmonary vein isolation in symptomatic atrial fibrillation (NCT04272762; East… View more
Author(s): Mirvat Alasnag , Khaled Al-Shaibi Added: 1 year ago
ESC Congress 24 – Day 1 of the ESC Congress 2024 was filled with excitement as new clinical practice guidelines were unveiled, along with several highly anticipated Hot Line trials.Interventional experts Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (King Fahd Armed Forces Hospital, SA) are concluding the first day by providing practical summaries of the key guidelines and offering critical insights… View more
Author(s): Harriette Van Spall , Stefan James Added: 1 year ago
What's hot at the ESC Congress 2024?Stay ahead of the curve with our faculty-led coverage of the European Society of Cardiology Congress in London. From groundbreaking trials to expert insights, we've got you covered.Watch ourView From the Thoraxcenterseries for practice-focused reviews of the most anticipated trials from interventional experts,Prof Nicolas Van MieghemandDr Joost Daemen.For a… View more
Author(s): Joost Daemen , Nicolas M Van Mieghem Added: 8 months ago
Dive into our coverage of ESC Congress 2025 for groundbreaking trial results and discussions with expert faculty.Watch ourView From the Thoraxcenterseries for practice-focused reviews of the most anticipated trials from interventional experts,Prof Nicolas Van MieghemandDr Joost Daemen. Watch our Wrap-Upseries led byDr Mirvat Alasnag summarising the key take-aways from each day of the congress.For… View more
Research Area(s) / Expertise:

Heart Failure

Job title: Professor of Internal Medicine and Chief of the Division of Cardiovascular Medicine
William T. Abraham, MD, grew up in western Pennsylvania near Pittsburgh, where he developed an early interest in science and medicine. He is married and has devoted the majority of his professional life to academic medicine, cardiovascular research, and the care of patients with advanced heart disease in the United States.Academic HistoryDr Abraham earned his medical degree from Harvard Medical… View more